Cargando…
Selecting Target Antigens for Cancer Vaccine Development
One of the principal goals of cancer immunotherapy is the development of efficient therapeutic cancer vaccines that are able to elicit an effector as well as memory T cell response specific to tumor antigens. In recent years, the attention has been focused on the personalization of cancer vaccines....
Autores principales: | Buonaguro, Luigi, Tagliamonte, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711972/ https://www.ncbi.nlm.nih.gov/pubmed/33080888 http://dx.doi.org/10.3390/vaccines8040615 |
Ejemplares similares
-
Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015) -
Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023) -
The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022) -
Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023) -
Corrigendum: Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)